All Stories

  1. MicroRNA-181b Controls Atherosclerosis and Aneurysms Through Regulation of TIMP-3 and ElastinNovelty and Significance

    Article • Circulation Research, October 2016, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson, Dr Stephen White

  2. IL-3 induced MMP-3 expression directs angiogensis and neovascularisation in atheroscelrosis

    Article • Atherosclerosis, January 2016, Elsevier

    Dr Jason L Johnson

  3. Galectin-3 regulates macrophage behaviour and modulates atherosclerotic plaque compostion

    Article • Atherosclerosis, January 2016, Elsevier

    Dr Jason L Johnson

  4. Differential effects of tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 on atherosclerosis and monocyte/macrophage invasion

    Article • Cardiovascular Research, December 2015, European Society of Cardiology

    Dr Jason L Johnson, Dr Jason Johnson

  5. N-cadherin and MMP7 modulate abdominal aortic aneurysm severity

    Article • Atherosclerosis, July 2015, Elsevier

    Dr Jason L Johnson

  6. Wnt5a-mediated rescue of vascular smooth muscle cells (VSMCs) from oxidative stress induced apoptosis is retarded with ageing

    Article • Atherosclerosis, July 2015, Elsevier

    Dr Jason L Johnson

  7. Wnt proteins retard macrophage foam cell formation and oxidised LDL induced apoptosis

    Article • Atherosclerosis, July 2015, Elsevier

    Dr Jason L Johnson

  8. Matrix metalloproteinases and their inhibitors in cardiovascular pathologies: current knowledge and clinical potential

    Article • Metalloproteinases In Medicine, December 2014, Taylor & Francis

    Dr Jason L Johnson

  9. Tissue inhibitor of metalloproteinase (TIMP)-2 retards MMP-14-dependent monocyte/macrophage invasion and modulates atherosclerosis

    Article • Atherosclerosis, December 2014, Elsevier

    Dr Jason L Johnson

  10. Regulation of foam cell formation, proliferation and apoptosis by Wnt signalling: implications for atherosclerosis

    Article • Atherosclerosis, December 2014, Elsevier

    Dr Jason L Johnson

  11. WISP-1/CCN4 is protective against athrosclerosis and vulnerability to pseudo-aneurysm in APOE/- knockout mice

    Article • Atherosclerosis, December 2014, Elsevier

    Dr Jason L Johnson

  12. Aneurysm severity is increased by EC4-FC (A ∼50KDA fragment of N-Cadherin) and MMP7 inhibition

    Article • Atherosclerosis, December 2014, Elsevier

    Dr Jason L Johnson

  13. Divergent effects of Wnts on vascular smooth muscle cell (VSMC) behaviour

    Article • Atherosclerosis, December 2014, Elsevier

    Dr Jason L Johnson

  14. Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis

    Article • Cardiovascular Research, July 2014, European Society of Cardiology

    Dr Jason L Johnson, Dr Jason Johnson

  15. MicroRNA-24 Regulates Macrophage Behavior and Retards Atherosclerosis

    Article • Arteriosclerosis Thrombosis and Vascular Biology, July 2014, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson, Dr Stephen White

  16. NEAR-INFRARED FLUORESCENCE (NIRF) WHOLE BODY AND INTRA-ARTERIAL MOLECULAR IMAGING OF OXIDIZED LDL IN EXPERIMENTAL ATHEROSCLEROSIS

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Jason L Johnson

  17. MicroRNA-181b inhibition reduces atherosclerosis by increasing macrophage TIMP-3 expression

    Article • Atherosclerosis, February 2014, Elsevier

    Dr Jason L Johnson

  18. Pro-inflammatory up-regulation of interleukin-3 receptor in endothelial cells modulates their migration and associated MMP expression

    Article • Atherosclerosis, February 2014, Elsevier

    Dr Jason L Johnson

  19. Dysfunctional Wnt signalling in ageing: Implications for cardiovascular disease

    Article • Atherosclerosis, February 2014, Elsevier

    Dr Jason L Johnson

  20. Wnt inducible soluble protein 1 (WISP-1) promotes VSMC migration and intimal thickening

    Article • Atherosclerosis, February 2014, Elsevier

    Dr Jason L Johnson

  21. Relationship of MMP-14 and TIMP-3 Expression with Macrophage Activation and Human Atherosclerotic Plaque Vulnerability

    Article • Mediators of Inflammation, January 2014, Hindawi Publishing Corporation

    Dr Jason L Johnson, Dr Jason Johnson

  22. Role of Matrix Metalloproteinases in Atherosclerosis

    Article • November 2013, Springer Science + Business Media

    Dr Jason L Johnson, Dr Jason Johnson

  23. Role of colony-stimulating factors in atherosclerosis

    Article • Current Opinion in Lipidology, October 2012, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  24. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

    Article • Journal of Clinical Investigation, February 2012, American Society for Clinical Investigation

    Dr Jason L Johnson, Dr Jason Johnson

  25. Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

    Article • Journal of Clinical Investigation, January 2012, American Society for Clinical Investigation

    Dr Jason L Johnson, Dr Jason Johnson

  26. Extracellular Matrix and Smooth Muscle Cells

    Article • November 2011, Springer Science + Business Media

    Dr Jason L Johnson, Dr Jason Johnson

  27. Matrix Metalloproteinase (MMP)-3 Activates MMP-9 Mediated Vascular Smooth Muscle Cell Migration and Neointima Formation in Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, June 2011, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  28. A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E-Knockout Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, January 2011, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  29. Increased expression of Wnt5A in unstable atherosclerotic plaques is associated with increased MMP expression and may contribute to instability

    Article • Atherosclerosis, November 2010, Elsevier

    Dr Jason L Johnson

  30. MMP-7 mediates cleavage of N-cadherin and promotes smooth muscle cell apoptosis

    Article • Cardiovascular Research, February 2010, European Society of Cardiology

    Dr Jason L Johnson, Dr Jason Johnson, Dr Stephen White

  31. In Situ Zymography

    Article • January 2010, Springer Science + Business Media

    Dr Jason L Johnson, Dr Jason Johnson

  32. Statin pleiotropism and atherosclerotic plaque rupture

    Article • Atherosclerosis, October 2009, Elsevier

    Dr Jason L Johnson, Dr Jason Johnson

  33. EFFECTS OF TISSUE INHIBITOR OF METALLOPROTEINASE (TIMP) DEFICIENCY ON MACROPHAGE INFILTRATION, PLAQUE STABILITY AND PSEUDO-ANEURYSMS

    Article • Atherosclerosis, August 2008, Elsevier

    Dr Jason L Johnson

  34. REDUCTION OF PLAQUE INSTABILITY BY SUPPRESSION OF VSMC APOPTOSIS WITH SOLUBLE N-CADHERIN

    Article • Atherosclerosis, August 2008, Elsevier

    Dr Jason L Johnson

  35. Tissue inhibitor of metalloproteinases (Timp)-3 down-regulation increases macrophage foam cell invasion, proliferation and death

    Article • Atherosclerosis, August 2007, Elsevier

    Dr Jason L Johnson

  36. Role of metalloproteinases in the vulnerable plaque

    Article • June 2007, Informa Healthcare

    Dr Jason L Johnson

  37. Assessment of Unstable Atherosclerosis in Mice

    Article • Arteriosclerosis Thrombosis and Vascular Biology, April 2007, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  38. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability

    Article • Expert Review of Cardiovascular Therapy, March 2007, Taylor & Francis

    Dr Jason L Johnson, Dr Jason Johnson

  39. Plaque rupture and vascular homeostasis

    Article • Vascular Pharmacology, September 2006, Elsevier

    Dr Jason L Johnson

  40. Suppression of Atherosclerotic Plaque Progression and Instability by Tissue Inhibitor of Metalloproteinase-2: Involvement of Macrophage Migration and Apoptosis

    Article • Circulation, May 2006, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  41. We-W37:2 Unstable plaque in laboratory animals: The apolipoprotein E knockout mouse fed a high-fat diet

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Dr Jason L Johnson

  42. Tu-P7:273 Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: Effects on macrophage behaviour

    Article • Atherosclerosis Supplements, January 2006, Elsevier

    Dr Jason L Johnson

  43. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries

    Article • Proceedings of the National Academy of Sciences, October 2005, Proceedings of the National Academy of Sciences

    Dr Jason L Johnson, Dr Jason Johnson

  44. Plaque Rupture After Short Periods of Fat Feeding in the Apolipoprotein E-Knockout Mouse: Model Characterization and Effects of Pravastatin Treatment

    Article • Circulation, March 2005, Wolters Kluwer Health

    Dr Jason L Johnson, Dr Jason Johnson

  45. 661 Matrix metalloproteinases-9 and -12 have opposite effects on atherosclerotic plaque stability

    Article • European Heart Journal, March 2003, Elsevier

    Dr Jason L Johnson

  46. 3HT03-3 Matrix metalloproteinases-9 and -12 have opposite effects on atherosclerotic plaque stability

    Article • Atherosclerosis Supplements, January 2003, Elsevier

    Dr Jason L Johnson

  47. Animal models of spontaneous plaque rupture: The holy grail of experimental atherosclerosis research

    Article • Current Atherosclerosis Reports, May 2002, Springer Science + Business Media

    Dr Jason L Johnson

  48. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse

    Article • Atherosclerosis, February 2001, Elsevier

    Dr Jason L Johnson, Dr Jason Johnson

  49. Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques

    Article • Arteriosclerosis Thrombosis and Vascular Biology, November 1998, Wolters Kluwer Health

    Dr Jason L Johnson

  50. In Situ Zymography

    Article • Springer Science + Business Media

    Dr Jason L Johnson

  51. Modulators of Monocyte and Macrophage Phenotypes in Atherosclerosis

    Article • Wiley

    Dr Jason L Johnson, Dr Jason Johnson